Extremely important positive changes in investment behavior have recently occurred for Atara Biotherapeutics Inc (NASDAQ: ATRA): the stock rose on very heavy volume, and its longer term price trend turned up.
Atara Biotherapeutics Inc (NASDAQ: ATRA). Notable positive changes in fundamentals have recently occurred: the stock’s power rating rose above 70, and the consensus estimate for December, 2025 increased significantly.
The stock is currently unrated.
Current PriceTarget Research Rating
Atara Biotherapeutics is currently unrated.
Recent Price Action
On 9/24/25, Atara Biotherapeutics Inc (NASDAQ: ATRA) stock enjoyed a very large increase of 9.9%, closing at $14.26. Moreover, exceptionally high trading volume at 329% of normal accompanied the advance. Relative to the market the stock has been strong over the last nine months and has risen 23.9% during the last week.
Be the first to comment